Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

CTA-Sticky-button.png clinicaltrialsyearbook+button

What to expect for 2018?

We are really excited to announce that represented on this year’s program include some of the most foremost and innovative biotechnology, pharmaceutical and medical device manufacturing companies within the industry; including Allium Medical, Neuroderm and Johnson & Johnson.

Across the two days, top senior-level representatives and decision makers will come together to discuss some of the most pressing challenges, objections and practical steps the sector can take towards outsourcing clinical studies. Further to this, presentation will be given from both incumbent and new entrant companies, to provide a wide scope of expertise and lessons learnt from experience.

This year’s edition has a strong focal point on the management of vendors throughout clinical trials. Throughout the first day, lectures will be given and discussions undertake will delve into optimal strategies that will illustrate how you can best manage a CROs and vendors, from top communication methods to best measurement tools and techniques that should be implemented to ensure timely and financially idealistic clinical trials.

We also delighted to welcome back the Ministry of Health, who are going to address key regulatory changes within clinical trial guidance to clarify ongoing ambiguity within the industry. This will be followed with an interactive question and answer session with their representative, to allow all your questions to be answered.

Day two will see two different streams within the event; biotech and medical device. There will be focused discussion around the key challenges these two sectors within the industry are facing, with a focal point on solutions to mitigate inefficiencies and enhance stringent resource allocation strategies.

Countdown to Outsourcing in Clinical Trials Israel 2018